Skip to content
‘Rest of Middle East may rely on India’: How Israel-Hamas war will impact Indian pharma exports
What Lies Ahead For Investors
Article on Alkyl Amines in Business Today Magazine
Biocon’s subsidiary Syngene’s shares drop 12% in 2022; here’s what management and analysts have to say
With Covid gone as a money spinner, what are companies like Cipla, Sun Pharma and Dr Reddy’s looking at?
The pharma sector presents a study in contrast; here’s why
Why is Temasek-Manipal Health Enterprises deal ‘premium’?
Rajesh Pherwani on Reliance Life Sciences